301Targeting the Gut Microbiome in Cardiovascular Disease: Current Therapeutic Strategies and Future Perspectives.2026 · Europe PMC
302Cardiovascular Disease as a Multisystem Disorder: Integrating Inflammation, Metabolism, and Organ Crosstalk.2026 · Europe PMC
303Cardiac structure and function in psoriasis: A cross-sectional analysis of the PSOCADIA study.2026 · Europe PMC
304Cardiovascular Implications of Diabetes Mellitus: A Systematic Literature Review.2026 · Europe PMC
305Disease Modifying Therapies for Chronic Rheumatic Heart Disease: Promise, Mechanisms, and the Road Ahead.2026 · Europe PMC
306Periprocedural Myocardial Infarction and Clinical Outcomes in Diffuse versus Focal Coronary Artery Disease.2026 · Europe PMC
307Research progress on the pathophysiological mechanisms of pioglitazone-induced heart failure: a review.2026 · Europe PMC
308Effects of Chronic Pain Medications on Cardiovascular Health: A Narrative Review.2026 · Europe PMC
309Neural-immune-cardiovascular axis: from mechanistic crosstalk to therapeutic targets in cardiovascular disease.2026 · Europe PMC
310Ribonucleic acid and gene therapies in cardiovascular disease: clinical applications, delivery challenges and emerging precision tools.2026 · Europe PMC
311Home-Based Cardiac Rehabilitation in Cardiovascular Diseases: A Narrative Review of Progress, Challenges, and Future Directions.2026 · Europe PMC
312Class effect beyond glucose: Implications of the LEGEND-T2DM findings for cardiovascular outcomes.2026 · Europe PMC
314Oxidative Stress in Vascular Aging: Therapeutic Potential of the Antioxidant Paradox. A State-of-the-Art Review.2026 · Europe PMC
315SGLT2 Inhibitors in Cardiovascular-Kidney-Metabolic Syndrome: Drugs Unifying Heart, Kidney, and Metabolism Pharmacotherapy.2026 · Europe PMC
316Patient-reported outcomes in studies of STereotactic arrhythmia Radioablation for ventricular tachycardia (PRO-STAR) - A scoping review on behalf of the STOPSTORM.Eu consortium.2026 · Europe PMC
317Cardiac regulatory mechanisms: Translating fundamental discoveries into novel therapeutics.2026 · Europe PMC
318Risk-Adaptive Cardio-Oncology Rehabilitation: A Narrative Review of Exercise Prescription, Multimodal Monitoring, and Implementation Pathways.2026 · Europe PMC
319Celiac Disease and Cardiovascular Disease: Epidemiology, Mechanisms, and Clinical Challenges.2026 · Europe PMC
320Microcurrent Therapy in Cardiac Repair: Bridging Mechanistic Biology and Clinical Evidence.2026 · Europe PMC
322Assessment of Cardiorespiratory Fitness in Individuals With Type 2 Diabetes Mellitus: Protocol for a Systematic Review and Meta-Analysis.2026 · Europe PMC
323Bench to Bedside: Insights from Large Animal Models and Emerging Clinical Trials of Endogenous Cardiac Regeneration and Repair.2026 · Europe PMC
324Stem Cell-Derived Cardiac and Conduction System Cells for Heart Regeneration and Repair: Current Progress and Future Directions.2026 · Europe PMC
325Effects of Gut Microbiota-Modulating Interventions on Systemic Inflammation and Functional Outcomes in Established Cardiovascular Disease: A Systematic Review.2026 · Europe PMC
326Concomitant use of SGLT2 inhibitors and GLP-1 receptor agonists in patients with heart failure.2026 · Europe PMC
327The Bone Marrow's Division of Labor in Cardiovascular Disease: A Scattered Organ Comes Into Focus.2026 · Europe PMC
328Glucagon-like Peptide-1 Receptor Agonists and Dual Incretin Therapies Across HFpEF and Cardiovascular Outcomes Trials in Patients with Obesity.2026 · Europe PMC
329Mediterranean Diet and Physical Exercise for Cardiometabolic Health: A Narrative Review.2026 · Europe PMC
330Cardiac Monitoring for Patients Undergoing Treatment With MEK Inhibitor Monotherapy.2026 · Europe PMC
332Protein arginine methyltransferases in cardiovascular disease: mechanisms, therapeutic potential, and future directions.2026 · Europe PMC
335Modifiable Lifestyle Factors in Cardiovascular Disease Prevention: Current Evidence and Future Directions.2026 · Europe PMC
336Long-term safety of CGRP pathway inhibitors in migraine patients with prior cerebrovascular or cardiovascular disease.2026 · Europe PMC
337Micronutrients in Cardiovascular Disease: A Comprehensive Review of Vitamins, Trace Minerals, and Electrolytes.2026 · Europe PMC
342Mesenchymal Stromal Cell Therapy in Cardiovascular Disease: Reconsidering Clinical Inconsistency Through the Mechanism-Endpoint Relationship.2026 · Europe PMC
343Balance and Mobility Impairment in Older Adults with Cardiovascular Disease Before and After Rehabilitation: A Narrative Review.2026 · Europe PMC
344Sexual Rehabilitation Interventions for Patients with Cardiovascular Disease: A Scoping Review.2026 · Europe PMC
346Impact of an oral amino acid-containing formulation on clinical and functional outcomes in patients with and without heart failure undergoing cardiac rehabilitation program: a pilot study.2026 · Europe PMC
348Management of Type 2 Diabetes: Selecting Amongst Available Pharmacological Agents2000 · Europe PMC